002693 *ST双成
已收盘 04-10 15:00:00
资讯
新帖
简况
*ST双成（002693）披露公司股票可能被终止上市的第五次风险提示性公告，4月3日股价下跌3.27%
证券之星 · 04-03
*ST双成（002693）披露公司股票可能被终止上市的第五次风险提示性公告，4月3日股价下跌3.27%
异动快报：*ST双成（002693）3月24日9点37分触及涨停板
证券之星 · 03-24
异动快报：*ST双成（002693）3月24日9点37分触及涨停板
*ST双成（002693）披露召开2026年第二次临时股东大会通知，3月23日股价下跌4.04%
证券之星 · 03-23
*ST双成（002693）披露召开2026年第二次临时股东大会通知，3月23日股价下跌4.04%
*ST双成（002693）披露2025年年度报告编制及最新审计进展情况公告，3月20日股价下跌1.98%
证券之星 · 03-20
*ST双成（002693）披露2025年年度报告编制及最新审计进展情况公告，3月20日股价下跌1.98%
异动快报：*ST双成（002693）3月18日10点59分触及涨停板
证券之星 · 03-18
异动快报：*ST双成（002693）3月18日10点59分触及涨停板
*ST双成（002693）披露公司股票可能被终止上市的第四次风险提示性公告，3月17日股价下跌2.86%
证券之星 · 03-17
*ST双成（002693）披露公司股票可能被终止上市的第四次风险提示性公告，3月17日股价下跌2.86%
异动快报：*ST双成（002693）3月16日13点25分触及涨停板
证券之星 · 03-16
异动快报：*ST双成（002693）3月16日13点25分触及涨停板
异动快报：*ST双成（002693）3月13日9点32分触及涨停板
证券之星 · 03-13
异动快报：*ST双成（002693）3月13日9点32分触及涨停板
*ST双成（002693）披露公司股票可能被终止上市的第三次风险提示性公告，3月3日股价下跌3.11%
证券之星 · 03-03
*ST双成（002693）披露公司股票可能被终止上市的第三次风险提示性公告，3月3日股价下跌3.11%
*ST双成：公司目前没有生物方面的研究
证券之星 · 01-29
*ST双成：公司目前没有生物方面的研究
*ST双成：公司2025年度业绩预告已于2026年1月27日发布
证券之星 · 01-29
*ST双成：公司2025年度业绩预告已于2026年1月27日发布
*ST双成（002693）披露公司股票可能被终止上市的风险提示性公告，1月26日股价上涨1.66%
证券之星 · 01-26
*ST双成（002693）披露公司股票可能被终止上市的风险提示性公告，1月26日股价上涨1.66%
*ST双成：预计2025年全年扣除后营业收入:24,500万元至28,500万元
证券之星 · 01-26
*ST双成：预计2025年全年扣除后营业收入:24,500万元至28,500万元
异动快报：*ST双成（002693）1月8日10点34分触及涨停板
证券之星 · 01-08
异动快报：*ST双成（002693）1月8日10点34分触及涨停板
*ST双成（002693）披露控股子公司通过高新技术企业认定，1月6日股价上涨1.54%
证券之星 · 01-06
*ST双成（002693）披露控股子公司通过高新技术企业认定，1月6日股价上涨1.54%
*ST双成：硼替佐米ANDA获FDA上市许可
证券之星 · 2025-12-25
*ST双成：硼替佐米ANDA获FDA上市许可
异动快报：*ST双成（002693）12月22日9点56分触及涨停板
证券之星 · 2025-12-22
异动快报：*ST双成（002693）12月22日9点56分触及涨停板
异动快报：*ST双成（002693）12月19日9点37分触及涨停板
证券之星 · 2025-12-19
异动快报：*ST双成（002693）12月19日9点37分触及涨停板
*ST双成(002693.SZ)：注射用硼替佐米ANDA获得美国FDA上市许可
智通财经 · 2025-12-18
*ST双成(002693.SZ)：注射用硼替佐米ANDA获得美国FDA上市许可
*ST双成：主营业务涵盖药品研发生产销售
证券之星 · 2025-12-09
*ST双成：主营业务涵盖药品研发生产销售
加载更多
公司概况
公司名称：
海南双成药业股份有限公司
所属行业：
医药制造业
上市日期：
2012-08-08
主营业务：
海南双成药业股份有限公司的主营业务是药品注射剂、固体制剂、原料药的研发、生产、销售。公司的主要产品是注射用生长抑素、注射用比伐芦定、依替巴肽注射液、醋酸奥曲肽注射液、注射用紫杉醇(白蛋白结合型)。公司曾荣获国家知识产权示范企业、优势企业奖励。
发行价格：
20.00
{"stockData":{"symbol":"002693","market":"SZ","secType":"STK","nameCN":"*ST双成","latestPrice":7.99,"timestamp":1775804586000,"preClose":8.02,"halted":0,"volume":5214500,"delay":0,"changeRate":-0.0037,"floatShares":411000000,"shares":415000000,"eps":-0.1037,"marketStatus":"已收盘","change":-0.03,"latestTime":"04-10 15:00:00","open":8.1,"high":8.13,"low":7.98,"amount":41964000,"amplitude":0.0187,"askPrice":8,"askSize":226,"bidPrice":7.99,"bidSize":951,"shortable":0,"etf":0,"ttmEps":-0.1037,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776043800000},"marketStatusCode":5,"adr":0,"adjPreClose":8.02,"symbolType":"stock","openAndCloseTimeList":[[1775784600000,1775791800000],[1775797200000,1775804400000]],"highLimit":8.42,"lowLimit":7.62,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":414689750,"isCdr":false,"pbRate":8.51,"roa":"--","roe":"--","epsLYR":-0.19,"committee":0.226899,"marketValue":3313000000,"turnoverRate":0.0127,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-04-13。","floatMarketCap":3284000000},"requestUrl":"/m/hq/s/002693","defaultTab":"news","newsList":[{"id":"2624265153","title":"*ST双成（002693）披露公司股票可能被终止上市的第五次风险提示性公告，4月3日股价下跌3.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624265153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624265153?lang=zh_cn&edition=full","pubTime":"2026-04-03 18:04","pubTimestamp":1775210663,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，*ST双成报收于7.68元，较前一交易日下跌3.27%，最新总市值为31.85亿元。该股当日开盘7.9元，最高8.01元，最低7.62元，成交额达6890.33万元，换手率为2.17%。海南双成药业股份有限公司于近日发布《关于公司股票可能被终止上市的第五次风险提示性公告》。根据深交所规定，若2025年度报告披露后触及相关终止上市情形之一，公司股票将面临被终止上市的风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300034968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621315970","title":"异动快报：*ST双成（002693）3月24日9点37分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2621315970","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621315970?lang=zh_cn&edition=full","pubTime":"2026-03-24 09:41","pubTimestamp":1774316479,"startTime":"0","endTime":"0","summary":"证券之星3月24日盘中消息，9点37分*ST双成触及涨停板。其所属行业化学制药目前上涨。领涨股为富祥药业。该股为化学原料药，肝炎概念，医药概念热股，当日化学原料药概念上涨2.14%，肝炎概念概念上涨2.09%，医药概念上涨2.03%。3月23日的资金流向数据方面，主力资金净流出924.85万元，占总成交额8.5%，游资资金净流入81.73万元，占总成交额0.75%，散户资金净流入843.12万元，占总成交额7.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400008768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621270478","title":"*ST双成（002693）披露召开2026年第二次临时股东大会通知，3月23日股价下跌4.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621270478","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621270478?lang=zh_cn&edition=full","pubTime":"2026-03-23 22:30","pubTimestamp":1774276239,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，*ST双成报收于7.61元，较前一交易日下跌4.04%，最新总市值为31.56亿元。近日，海南双成药业股份有限公司发布《关于召开2026年第二次临时股东会的通知》。公告显示，公司将于2026年4月8日召开2026年第二次临时股东会，会议由董事会召集，现场会议时间为当日14:30，网络投票时间为当日9:15至15:00。其中，第一项议案涉及关联交易，关联股东需回避表决；第三项为特别决议议案，须经出席会议股东所持表决权的三分之二以上通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300039916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620763781","title":"*ST双成（002693）披露2025年年度报告编制及最新审计进展情况公告，3月20日股价下跌1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620763781","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620763781?lang=zh_cn&edition=full","pubTime":"2026-03-20 17:23","pubTimestamp":1773998637,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，*ST双成报收于7.93元，较前一交易日下跌1.98%，最新总市值为32.88亿元。海南双成药业股份有限公司于近日发布《关于2025年年度报告编制及最新审计进展情况的公告》。公司预计2025年度净利润为正值且扭亏为盈，但最终数据以经审计的2025年年度报告为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000030232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620283741","title":"异动快报：*ST双成（002693）3月18日10点59分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2620283741","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620283741?lang=zh_cn&edition=full","pubTime":"2026-03-18 11:01","pubTimestamp":1773802863,"startTime":"0","endTime":"0","summary":"证券之星3月18日盘中消息，10点59分*ST双成触及涨停板。其所属行业化学制药目前上涨。领涨股为莎普爱思。该股为半导体，医药，阿尔茨海默病概念热股，当日半导体概念上涨0.65%，医药概念上涨0.09%。3月17日的资金流向数据方面，主力资金净流出1325.95万元，占总成交额8.46%，游资资金净流入107.39万元，占总成交额0.69%，散户资金净流入1218.56万元，占总成交额7.78%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800015135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620170473","title":"*ST双成（002693）披露公司股票可能被终止上市的第四次风险提示性公告，3月17日股价下跌2.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620170473","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620170473?lang=zh_cn&edition=full","pubTime":"2026-03-17 22:23","pubTimestamp":1773757397,"startTime":"0","endTime":"0","summary":"截至2026年3月17日收盘，*ST双成报收于7.82元，较前一交易日下跌2.86%，最新总市值为32.43亿元。近日，海南双成药业股份有限公司发布《关于公司股票可能被终止上市的第四次风险提示性公告》。根据深交所规定，若2025年度报告披露后触及相关终止上市情形之一，公司股票将面临被终止上市的风险。公司已披露第四次风险提示公告，提醒投资者注意投资风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700042053.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619396084","title":"异动快报：*ST双成（002693）3月16日13点25分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2619396084","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619396084?lang=zh_cn&edition=full","pubTime":"2026-03-16 13:30","pubTimestamp":1773639054,"startTime":"0","endTime":"0","summary":"证券之星3月16日盘中消息，13点25分*ST双成触及涨停板。其所属行业化学制药目前上涨。领涨股为新诺威。该股为半导体，肝炎概念，阿尔茨海默病概念热股，当日半导体概念上涨2.04%，肝炎概念概念上涨0.78%，阿尔茨海默病概念上涨0.65%。3月13日的资金流向数据方面，主力资金净流入740.69万元，占总成交额9.46%，游资资金净流出99.24万元，占总成交额1.27%，散户资金净流出641.45万元，占总成交额8.2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600013838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619156127","title":"异动快报：*ST双成（002693）3月13日9点32分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2619156127","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619156127?lang=zh_cn&edition=full","pubTime":"2026-03-13 09:35","pubTimestamp":1773365751,"startTime":"0","endTime":"0","summary":"证券之星3月13日盘中消息，9点32分*ST双成（002693）触及涨停板。其所属行业化学制药目前下跌。领涨股为能特科技。该股为阿尔茨海默病，半导体，医药概念热股，当日阿尔茨海默病概念上涨0.04%。3月12日的资金流向数据方面，主力资金净流出19.88万元，占总成交额0.95%，游资资金净流入136.54万元，占总成交额6.56%，散户资金净流出116.66万元，占总成交额5.6%。近5日资金流向一览见下表：*ST双成主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300008987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616532114","title":"*ST双成（002693）披露公司股票可能被终止上市的第三次风险提示性公告，3月3日股价下跌3.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616532114","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616532114?lang=zh_cn&edition=full","pubTime":"2026-03-03 23:04","pubTimestamp":1772550259,"startTime":"0","endTime":"0","summary":"截至2026年3月3日收盘，*ST双成报收于7.16元，较前一交易日下跌3.11%，最新总市值为29.69亿元。近日，海南双成药业股份有限公司发布《关于公司股票可能被终止上市的第三次风险提示性公告》。根据相关规定，若公司2025年度报告出现经审计的利润为负且扣除后营收低于3亿元、净资产为负或财务报告被出具非标意见等情形之一，公司股票将面临终止上市风险。公司已披露三次风险提示公告，最终财务数据以经审计的2025年年度报告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300044868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607087893","title":"*ST双成：公司目前没有生物方面的研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2607087893","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607087893?lang=zh_cn&edition=full","pubTime":"2026-01-29 20:51","pubTimestamp":1769691102,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成(002693)01月28日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司在生物方面有哪些研究？*ST双成回复：尊敬的投资者您好，公司目前没有生物方面的研究，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900040890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607082032","title":"*ST双成：公司2025年度业绩预告已于2026年1月27日发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2607082032","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607082032?lang=zh_cn&edition=full","pubTime":"2026-01-29 20:51","pubTimestamp":1769691102,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成(002693)01月28日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司能否按时披露2025业绩预告？请接受退市现实，别再拖了！*ST双成回复：尊敬的投资者您好，公司2025年度业绩预告已于2026年1月27日发布，详见公司在指定信息披露媒体发布的公告，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900040887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606424904","title":"*ST双成（002693）披露公司股票可能被终止上市的风险提示性公告，1月26日股价上涨1.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606424904","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606424904?lang=zh_cn&edition=full","pubTime":"2026-01-26 23:03","pubTimestamp":1769439810,"startTime":"0","endTime":"0","summary":"截至2026年1月26日收盘，*ST双成报收于7.95元，较前一交易日上涨1.66%，最新总市值为32.97亿元。该股当日开盘7.8元，最高7.99元，最低7.78元，成交额达5175.49万元，换手率为1.6%。近日，海南双成药业股份有限公司发布《关于公司股票可能被终止上市的风险提示性公告》。根据相关规定，若公司2025年度报告出现经审计的净利润为负且扣除后的营业收入低于3亿元等情形之一，公司股票将面临被终止上市的风险。公司提示投资者注意投资风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600037264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606421797","title":"*ST双成：预计2025年全年扣除后营业收入:24,500万元至28,500万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606421797","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606421797?lang=zh_cn&edition=full","pubTime":"2026-01-26 20:01","pubTimestamp":1769428898,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成发布业绩预告，预计2025年全年扣除后营业收入:24,500万元至28,500万元。公告中解释本次业绩变动的原因为：预计本报告期利润总额同比增长 107.53%-111.30%、归属于上市公司股东的净利润同比增长 120.43%-129.37%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600031070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601367023","title":"异动快报：*ST双成（002693）1月8日10点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2601367023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601367023?lang=zh_cn&edition=full","pubTime":"2026-01-08 10:35","pubTimestamp":1767839722,"startTime":"0","endTime":"0","summary":"证券之星1月8日盘中消息，10点34分*ST双成触及涨停板。其所属行业化学制药目前上涨。领涨股为必贝特。该股为肝炎概念，阿尔茨海默病，化学原料药概念热股，当日肝炎概念概念上涨1.24%，阿尔茨海默病概念上涨1.19%，化学原料药概念上涨0.89%。1月7日的资金流向数据方面，主力资金净流入337.6万元，占总成交额8.08%，游资资金净流出175.47万元，占总成交额4.2%，散户资金净流出162.13万元，占总成交额3.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800011319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601132028","title":"*ST双成（002693）披露控股子公司通过高新技术企业认定，1月6日股价上涨1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601132028","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601132028?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:30","pubTimestamp":1767709837,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘，*ST双成报收于7.26元，较前一交易日上涨1.54%，最新总市值为30.11亿元。该股当日开盘7.15元，最高7.35元，最低7.14元，成交额达5648.32万元，换手率为1.9%。公司近日发布公告称，其控股子公司宁波双成药业有限公司被认定为宁波市2025年度第一批高新技术企业，证书编号GR202533101446，发证日期2025年12月8日，有效期三年。本次为首次认定，根据相关规定，宁波双成在三年内将按15%的税率缴纳企业所得税。该事项不会对公司当期经营业绩产生影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600042591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594234050","title":"*ST双成：硼替佐米ANDA获FDA上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2594234050","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594234050?lang=zh_cn&edition=full","pubTime":"2025-12-25 20:51","pubTimestamp":1766667100,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成(002693)12月24日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司的硼替佐米美国订单是否落地？FDA相关进展如何？*ST双成回复：尊敬的投资者您好，公司产品注射用硼替佐米ANDA已获得美国FDA上市许可，详见公司于2025年12月19日披露的公告。感谢你的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500033367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593717202","title":"异动快报：*ST双成（002693）12月22日9点56分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2593717202","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593717202?lang=zh_cn&edition=full","pubTime":"2025-12-22 10:01","pubTimestamp":1766368876,"startTime":"0","endTime":"0","summary":"证券之星12月22日盘中消息，9点56分*ST双成触及涨停板。其所属行业化学制药目前上涨。领涨股为康芝药业。该股为海南概念，半导体，化学原料药概念热股，当日海南概念概念上涨8.26%，半导体概念上涨1.78%，化学原料药概念上涨0.06%。12月19日的资金流向数据方面，主力资金净流入1292.69万元，占总成交额26.02%，游资资金净流出183.2万元，占总成交额3.69%，散户资金净流出1109.49万元，占总成交额22.33%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200003362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592361731","title":"异动快报：*ST双成（002693）12月19日9点37分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2592361731","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592361731?lang=zh_cn&edition=full","pubTime":"2025-12-19 09:41","pubTimestamp":1766108469,"startTime":"0","endTime":"0","summary":"证券之星12月19日盘中消息，9点37分*ST双成触及涨停板。其所属行业化学制药目前上涨。领涨股为河化股份。该股为海南概念，肝炎概念，化学原料药概念热股，当日海南概念概念上涨0.57%，肝炎概念概念上涨0.27%，化学原料药概念上涨0.21%。12月18日的资金流向数据方面，主力资金净流出430.47万元，占总成交额13.42%，游资资金净流入299.45万元，占总成交额9.33%，散户资金净流入131.02万元，占总成交额4.08%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900006464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592097519","title":"*ST双成(002693.SZ)：注射用硼替佐米ANDA获得美国FDA上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2592097519","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592097519?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:24","pubTimestamp":1766046271,"startTime":"0","endTime":"0","summary":"智通财经APP讯，*ST双成(002693.SZ)公告，公司近日收到美国食品和药品监督管理局(简称“FDA”)的通知，公司向美国FDA提交的注射用硼替佐米简略新药申请(简称“ANDA”)已获得美国FDA的批准。美国FDA对公司递交的注射用硼替佐米ANDA申报资料进行了全面技术审评，认定公司的产品与原研药品生物等效和疗效等效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"*ST双成(002693.SZ)：注射用硼替佐米ANDA获得美国FDA上市许可","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590134629","title":"*ST双成：主营业务涵盖药品研发生产销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2590134629","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590134629?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:51","pubTimestamp":1765284693,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成(002693)12月08日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司是否考虑过向不同领域开展业务？*ST双成回复：尊敬的投资者您好，公司所属行业为医药制造业，公司主营业务涵盖药品注射剂、固体制剂、原料药的研发、生产、销售等，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900037434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775857408919,"stockEarnings":[{"period":"1week","weight":0.0404},{"period":"1month","weight":0.0915},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.035},{"period":"1year","weight":0.0076},{"period":"ytd","weight":0.148}],"compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":-0.0356},{"period":"3month","weight":-0.0326},{"period":"6month","weight":0.0229},{"period":"1year","weight":0.2366},{"period":"ytd","weight":0.0044}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"海南双成药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"44166人(较上一季度减少19.43%)","perCapita":"9305股","listingDate":"2012-08-08","address":"海南省海口市秀英区兴国路16号","registeredCapital":"41468万元","survey":" 海南双成药业股份有限公司的主营业务是药品注射剂、固体制剂、原料药的研发、生产、销售。公司的主要产品是注射用生长抑素、注射用比伐芦定、依替巴肽注射液、醋酸奥曲肽注射液、注射用紫杉醇(白蛋白结合型)。公司曾荣获国家知识产权示范企业、优势企业奖励。","listedPrice":20},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"*ST双成(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供*ST双成(002693)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"*ST双成,002693,*ST双成股票,*ST双成股票老虎,*ST双成股票老虎国际,*ST双成行情,*ST双成股票行情,*ST双成股价,*ST双成股市,*ST双成股票价格,*ST双成股票交易,*ST双成股票购买,*ST双成股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"*ST双成(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供*ST双成(002693)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}